-
-
-
-
-
-
-
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
-
-
-
-
-
-
-
InterCure Ltd (INCR) secures NIS 66M in funding to support the recovery of Nir Oz Facility
-
-
-
-
-
-
-
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
-
-
-
-
-
-
-
InterCure Wins Cannolam Arbitration Proceeding
-
-
-
-
-
-
-
InterCure Reschedules 2022 Full Year Results Conference Call
-
-
-
-
-
-
-
InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY
-
-
-
-
-
-
-
InterCure to Release its Q1 2022 Results and Hold a Conference Call
-
1,223,760 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

